Milad Shirvaliloo

1.0k citations
43 papers · 701 indexed · h-index 16
Topics
Nanoparticle-Based Drug Delivery (11 papers)COVID-19 Clinical Research Studies (10 papers)SARS-CoV-2 and COVID-19 Research (8 papers)
Journals
SHILAP Revista de lepidopterologíaThe FASEB JournalApplied Microbiology and Biotechnology
Partner nations
IranTürkiyePoland

In The Last Decade

Milad Shirvaliloo

42 papers receiving 687 citations

Peers

Milad Shirvaliloo
Comparison fields: 5 of 103
  • Molecular Biology 314
  • Infectious Diseases 151
  • Biomedical Engineering 134
  • Cancer Research 133
  • Biomaterials 110
Replace Ron Kleiner with:
Ron Kleiner Israel
Feng Pan China
Fu‐Fei Hsu Taiwan
Shipra Sharma India
Yuefei Zhu United States
Stephanie M. Bates United Kingdom
Enguo Chen China
Xuxia Wang China
Milad Shirvaliloo relative to Ron Kleiner Israel Ron Kleiner's profile →
Citations per field
00.5×5.1×
Ron Kleiner · 1×
Citations per year

Countries citing papers authored by Milad Shirvaliloo

Since Specialization
Citations

This map shows the geographic impact of Milad Shirvaliloo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Milad Shirvaliloo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Milad Shirvaliloo more than expected).

Fields of papers citing papers by Milad Shirvaliloo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Milad Shirvaliloo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Milad Shirvaliloo. The network helps show where Milad Shirvaliloo may publish in the future.

Co-authorship network of co-authors of Milad Shirvaliloo

This figure shows the co-authorship network connecting the top 25 collaborators of Milad Shirvaliloo. A scholar is included among the top collaborators of Milad Shirvaliloo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Milad Shirvaliloo. Milad Shirvaliloo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 5
2 4
3 1
4 8
5 8
6 1
7 17
8 2
9 4
10 7
11 14
12 14
13 69
14 15
15 30
16 38
17 3
18 16
19 22
20 52

About Milad Shirvaliloo

Milad Shirvaliloo is a scholar working on Biomaterials, Infectious Diseases and Cancer Research, having authored 43 papers that have together received 701 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (11 papers), COVID-19 Clinical Research Studies (10 papers) and SARS-CoV-2 and COVID-19 Research (8 papers). The work is most often cited by research in Cancer Research (133 citations), Biomaterials (110 citations) and Infectious Diseases (151 citations). Milad Shirvaliloo has collaborated with scholars based in Iran, Türkiye and Poland. Frequent co-authors include Roghayeh Sheervalilou, Saman Sargazi, Habib Ghaznavi, Sakine Shirvalilou, Samideh Khoei, Parisa Shiri Aghbash, Hossein Bannazadeh Baghi, Younes Pilehvar‐Soltanahmadi, Hajie Lotfi and Farhad Jadidi‐Niaragh. Their work appears in journals such as SHILAP Revista de lepidopterología, The FASEB Journal and Applied Microbiology and Biotechnology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026